
Magellan Health, Inc. MGLN
Magellan Health, Inc. ROCE Ratio 2011-2026 | MGLN
Annual ROCE Ratio Magellan Health, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 0.78 | 4.48 | 3.1 | 7.52 | 11.32 | 5.62 | 8.22 | 12.95 | 16.9 | 20.01 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.01 | 0.78 | 9.09 |
ROCE Ratio of other stocks in the Health care industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
16.41 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
22.06 | $ 272.6 | -0.92 % | $ 71.8 B | ||
|
Triple-S Management Corporation
GTS
|
0.18 | - | 0.28 % | $ 847 M | ||
|
CVS Health Corporation
CVS
|
6.2 | $ 77.62 | -0.6 % | $ 98.3 B | ||
|
Centene Corporation
CNC
|
-38.2 | $ 37.26 | -0.56 % | $ 18.4 B | ||
|
Molina Healthcare
MOH
|
19.19 | $ 147.51 | -1.65 % | $ 7.79 B | ||
|
NovoCure Limited
NVCR
|
-26.47 | $ 11.3 | 5.41 % | $ 1.26 B | ||
|
UnitedHealth Group Inc.
UNH
|
18.95 | $ 314.19 | 0.38 % | $ 285 B | ||
|
Humana
HUM
|
15.31 | $ 196.21 | -1.02 % | $ 23.6 B |